As of 2024-12-11, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (7.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.45 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -178.3%.
The range of the Relative Valuation is (3.18) - (11.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 18.4x | 11.8x |
| Forward P/E multiples | 5.1x - 18.9x | 12.0x |
| Fair Price | (3.18) - (11.47) | (7.40) |
| Upside | -133.6% - -221.4% | -178.3% |
| Date | P/E |
| 2024-11-29 | -14.94 |
| 2024-11-27 | -14.97 |
| 2024-11-26 | -15.05 |
| 2024-11-25 | -4.59 |
| 2024-11-22 | -4.38 |
| 2024-11-21 | -4.35 |
| 2024-11-20 | -4.36 |
| 2024-11-19 | -4.44 |
| 2024-11-18 | -4.28 |
| 2024-11-15 | -4.43 |
| 2024-11-14 | -5.15 |
| 2024-11-13 | -5.26 |
| 2024-11-12 | -5.92 |
| 2024-11-11 | -5.95 |
| 2024-11-08 | -4.94 |
| 2024-11-07 | -4.70 |
| 2024-11-06 | -4.46 |
| 2024-11-05 | -4.27 |
| 2024-11-04 | -4.06 |
| 2024-11-01 | -3.96 |
| 2024-10-31 | -3.80 |
| 2024-10-30 | -3.82 |
| 2024-10-29 | -3.93 |
| 2024-10-28 | -3.98 |
| 2024-10-25 | -3.87 |
| 2024-10-24 | -3.88 |
| 2024-10-23 | -4.01 |
| 2024-10-22 | -4.01 |
| 2024-10-21 | -4.01 |
| 2024-10-18 | -3.93 |
| 2024-10-17 | -4.07 |
| 2024-10-16 | -4.07 |
| 2024-10-15 | -4.07 |
| 2024-10-14 | -4.01 |
| 2024-10-11 | -4.03 |
| 2024-10-10 | -3.96 |
| 2024-10-09 | -4.11 |
| 2024-10-08 | -4.12 |
| 2024-10-07 | -4.27 |
| 2024-10-04 | -4.19 |
| 2024-10-03 | -4.07 |
| 2024-10-02 | -4.24 |
| 2024-10-01 | -4.41 |
| 2024-09-30 | -4.59 |
| 2024-09-27 | -4.65 |
| 2024-09-26 | -4.76 |
| 2024-09-25 | -4.81 |
| 2024-09-24 | -4.94 |
| 2024-09-23 | -4.96 |
| 2024-09-20 | -5.41 |